Key facts
- This page summarizes Mira Jung's Form 4 filing for Shuttle Pharmaceuticals Holdings, Inc. (SHPH).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 09 Oct 2024, 17:00.
Mira Jung - 01 May 2024 Form 4 Insider Report for Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
- Reporting relationship
- Chief Scientific Officer
- Issuer ticker
- SHPH
- Reported as of
- 01 May 2024
- Net transaction value
- -$6,745
- SEC form
- 4
- Accepted by SEC
- 09 Oct 2024, 17:00:06 UTC
- Prior SEC filing
- 03 Jan 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Mira Jung
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Mira Jung filed Form 4 for Shuttle Pharmaceuticals Holdings, Inc. (SHPH) on 09 Oct 2024.
Change
- Previous filing in this sequence was filed on 03 Jan 2023.
- Current net transaction value: -$6,745.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SHPH
transaction
CLASS A COMMON STOCK
Award
- Transaction value
- $6,745
- Shares
- -598
- Change %
- -0.44%
- Price
- $11.28
- Shares after
- 135,715
- Date
- 01 May 2024
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The Reporting Person received a grant of 1,791 restricted stock units ("RSUs") on May 1, 2023 (14,326 RSUs on a pre-reverse split basis), which RSUs are subject to vesting over a period of three years. The first vesting of 598 RSUs occurred on May 1, 2024.
Footnote F2
Consists of (i) 134,522 shares of common stock and (ii) 1,193 RSUs which remain subject to vesting. All share and RSU numbers reflect a 1-for-8 reverse stock split effected by the issuer on August 13, 2024.